Literature DB >> 27798047

Common diseases as determinants of menopausal age.

Jingmei Li1, Mikael Eriksson1, Kamila Czene1, Per Hall1, Kenny A Rodriguez-Wallberg2,3.   

Abstract

STUDY QUESTION: Can the diagnosis of common diseases before menopause influence age at natural menopause (ANM) onset? SUMMARY ANSWER: Polycystic ovary syndrome (PCOS) and depression were observed to delay menopause. WHAT IS KNOWN ALREADY: It has been observed that women who undergo early menopause experience a higher burden of health problems related to metabolic syndromes, heart disease and depression, but whether ANM can be influenced by common adult diseases has not been studied extensively. STUDY DESIGN, SIZE, DURATION: All women attending mammography screening or clinical mammography at four hospitals in Sweden were invited to participate in the Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA) study. Between January 2011 and March 2013, 70 877 women were recruited. Information from the baseline questionnaire filled out upon enrollment was used in this cross-sectional analysis on predictors of ANM onset. PARTICIPANTS/MATERIALS, SETTING,
METHODS: We limited our analyses to 61 936 women with complete data on ANM and covariates and a follow-up time (from birth to menopause or censoring) of at least 35 years. Premenopausal diagnoses of depression, anorexia, bulimia, PCOS, ovarian cyst, heart failure, myocardial infarction, angina pectoris, stroke, preeclampsia, diabetes, hypertension and hyperlipidemia were examined as time-dependent variables in multivariable Cox regression analyses, adjusting for reproductive factors (age at menarche, menstrual cycle regularity in adult life, number of children and premenopausal oral contraceptive use) and risk factors of common diseases (education, physical activity at 18 years and information at the time of questionnaire including BMI, ever smoking and alcohol consumption). MAIN RESULTS AND THE ROLE OF CHANCE: Women with PCOS and depression were independently associated with later menopause (hazard ratio (95% CI): 0.44 (0.28-0.71) and 0.95 (0.91-1.00), respectively), compared to women with no such histories. The associations remained significant in a subset of women who had never received gynecological surgery or hormone treatment (n = 32313, 0.21 (0.08-0.50) and 0.91 (0.85-0.98), respectively). None of the other diseases examined were significantly associated with ANM. LIMITATIONS, REASONS FOR CAUTION: Information from the questionnaire was self-reported, making recall possible, but it is unlikely that any bias was different in the strata of different factors considered. Misclassification could also have occurred in cases where the diagnoses of common diseases were close to age at last follow-up. In addition, observational studies cannot establish that the associations identified represent cause-and-effect relationships. WIDER IMPLICATIONS OF THE
FINDINGS: Our study is the first in examining multiple common diseases simultaneously as determinants of ANM. Contrary to previous reports, we did not find any significant accelerating effect of hypertension, cardiovascular disease and diabetes on ANM. STUDY FUNDING/COMPETING INTERESTS: KARMA was financed by the Märit and Hans Rausing's Initiative Against Breast Cancer. K.R.W. is supported by the Swedish Society of Medicine and by Stockholm County Council. J.L. is a recipient of an Alex and Eva Wallström Foundation award. The authors declare that there is no conflict of interest regarding the publication of this paper.
© The Author 2016. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  epidemiology; menopause; ovarian reserve; polycystic ovaries; vascular system

Mesh:

Year:  2016        PMID: 27798047     DOI: 10.1093/humrep/dew264

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  13 in total

1.  Lifelong estradiol exposure and risk of depressive symptoms during the transition to menopause and postmenopause.

Authors:  Wendy K Marsh; Joyce T Bromberger; Sybil L Crawford; Katherine Leung; Howard M Kravitz; John F Randolph; Hadine Joffe; Claudio N Soares
Journal:  Menopause       Date:  2017-12       Impact factor: 2.953

2.  Posttraumatic stress disorder symptoms and timing of menopause and gynecological surgery in the Nurses' Health Study II.

Authors:  Kristen Nishimi; Rebecca C Thurston; Lori B Chibnik; Andrea L Roberts; Jennifer A Sumner; Rebecca B Lawn; Shelley S Tworoger; Yongjoo Kim; Karestan C Koenen; Laura D Kubzansky
Journal:  J Psychosom Res       Date:  2022-05-21       Impact factor: 4.620

3.  Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists.

Authors:  Angela H E M Maas; Giuseppe Rosano; Renata Cifkova; Alaide Chieffo; Dorenda van Dijken; Haitham Hamoda; Vijay Kunadian; Ellen Laan; Irene Lambrinoudaki; Kate Maclaran; Nick Panay; John C Stevenson; Mick van Trotsenburg; Peter Collins
Journal:  Eur Heart J       Date:  2021-03-07       Impact factor: 29.983

4.  Genetically Determined Reproductive Aging and Coronary Heart Disease: A Bidirectional 2-sample Mendelian Randomization.

Authors:  Veerle Dam; N Charlotte Onland-Moret; Stephen Burgess; Maria-Dolores Chirlaque; Sanne A E Peters; Ewoud Schuit; Kaja Tikk; Elisabete Weiderpass; Clare Oliver-Williams; Angela M Wood; Anne Tjønneland; Christina C Dahm; Kim Overvad; Marie-Christine Boutron-Ruault; Matthias B Schulze; Antonia Trichopoulou; Pietro Ferrari; Giovanna Masala; Vittorio Krogh; Rosario Tumino; Giuseppe Matullo; Salvatore Panico; Jolanda M A Boer; W M Monique Verschuren; Marit Waaseth; Maria José Sánchez Pérez; Pilar Amiano; Liher Imaz; Conchi Moreno-Iribas; Olle Melander; Sophia Harlid; Maria Nordendahl; Patrik Wennberg; Timothy J Key; Elio Riboli; Carmen Santiuste; Rudolf Kaaks; Verena Katzke; Claudia Langenberg; Nicholas J Wareham; Heribert Schunkert; Jeanette Erdmann; Christina Willenborg; Christian Hengstenberg; Marcus E Kleber; Graciela Delgado; Winfried März; Stavroula Kanoni; George Dedoussis; Panos Deloukas; Majid Nikpay; Ruth McPherson; Markus Scholz; Andrej Teren; Adam S Butterworth; Yvonne T van der Schouw
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

5.  Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.

Authors:  Jaakko S Tyrmi; Riikka K Arffman; Natàlia Pujol-Gualdo; Venla Kurra; Laure Morin-Papunen; Eeva Sliz; Terhi T Piltonen; Triin Laisk; Johannes Kettunen; Hannele Laivuori
Journal:  Hum Reprod       Date:  2022-01-28       Impact factor: 6.918

6.  Markers of gastrointestinal permeability and dysbiosis in premenopausal women with PCOS: a case-control study.

Authors:  Shilpa Lingaiah; Riikka K Arffman; Laure Morin-Papunen; Juha S Tapanainen; Terhi Piltonen
Journal:  BMJ Open       Date:  2021-07-05       Impact factor: 2.692

7.  The relation of age at menarche with age at natural menopause: a population study of 336 788 women in Norway.

Authors:  E K Bjelland; S Hofvind; L Byberg; A Eskild
Journal:  Hum Reprod       Date:  2018-06-01       Impact factor: 6.918

8.  The Association between Oligomenorrhea, Onset of Menopause and Metabolic Syndrome in Thai Postmenopausal Women.

Authors:  Siripen Ongsupharn; Tawiwan Pantasri; Worashorn Lattiwongsakorn; Nuntana Morakote
Journal:  J Menopausal Med       Date:  2018-08-31

9.  Higher menopausal age but no differences in parity in women with polycystic ovary syndrome compared with controls.

Authors:  Maria Forslund; Kerstin Landin-Wilhelmsen; Johanna Schmidt; Mats Brännström; Penelope Trimpou; Eva Dahlgren
Journal:  Acta Obstet Gynecol Scand       Date:  2018-11-15       Impact factor: 3.636

Review 10.  Ovarian Follicle Depletion Induced by Chemotherapy and the Investigational Stages of Potential Fertility-Protective Treatments-A Review.

Authors:  Xia Hao; Amandine Anastácio; Kui Liu; Kenny A Rodriguez-Wallberg
Journal:  Int J Mol Sci       Date:  2019-09-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.